Enanta Pharmaceuticals Inc (ENTA) — Cash Flow Reinvestment Rate
Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Reinvestment Rate of 1.52x as of June 2025, reinvesting $26.64 Million (capex $155.00K plus investments $-26.48 Million) from operating cash flow of $17.51 Million. See Enanta Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Enanta Pharmaceuticals Inc Cash Flow Reinvestment Rate (2011–2020)
Historical reinvestment intensity for Enanta Pharmaceuticals Inc across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Enanta Pharmaceuticals Inc.
Annual Cash Flow Reinvestment Rate for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year capital reinvestment analysis for Enanta Pharmaceuticals Inc. See financial agility of Enanta Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.21x | $22.72 Million | $7.09 Million | $1.45 Million | ▲ +164.2% |
| 2019 | 1.21x | $86.66 Million | $71.42 Million | $5.42 Million | ▼ -7.6% |
| 2018 | 1.31x | $38.38 Million | $29.22 Million | $2.98 Million | ▲ +1412.8% |
| 2017 | 0.09x | $4.57 Million | $52.65 Million | $2.51 Million | ▼ -92.9% |
| 2016 | 1.22x | $43.66 Million | $35.81 Million | $4.74 Million | ▲ +6.2% |
| 2015 | 1.15x | $88.02 Million | $76.67 Million | $2.34 Million | ▲ +808.5% |
| 2014 | 0.13x | $2.55 Million | $20.18 Million | $1.03 Million | ▼ -98.1% |
| 2013 | 6.50x | $69.22 Million | $10.65 Million | $606.00K | ▲ +58229.0% |
| 2012 | 0.01x | $252.00K | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $445.00K | $24.02 Million | $445.00K | — |